We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Universal Corp
UVV
$1.31B
| $3.2M | 0.01% |
45,237
+13,590
| +43% | +$947K |
|
|
NTRI
1277
DELISTED
NutriSystem, Inc.
NTRI
| $3.2M | 0.01% |
57,620
+17,018
| +42% | +$703K |
|
1278
Insight Enterprises
NSIT
$3.89B
| $3.19M | 0.01% |
77,578
+19,211
| +33% | +$785K |
|
|
DATA
1279
DELISTED
Tableau Software, Inc.
DATA
| $3.18M | 0.01% |
64,208
+5,298
| +9% | +$262K |
|
1280
Forward Air
FWRD
$444M
| $3.17M | 0.01% |
66,644
+558
| +0.8% | +$27.1K |
|
1281
Axos Financial
AX
$5.77B
| $3.17M | 0.01% |
121,297
+31,718
| +35% | +$916K |
|
1282
Rogers Corp
ROG
$2.21B
| $3.17M | 0.01% |
36,895
+9,770
| +36% | +$799K |
|
1283
3D Systems Corp
DDD
$431M
| $3.16M | 0.01% |
211,461
+7,994
| +4% | +$125K |
|
1284
Essent Group
ESNT
$6.08B
| $3.16M | 0.01% |
87,395
+5,305
| +6% | +$184K |
|
1285
Cleveland-Cliffs
CLF
$6.57B
| $3.16M | 0.01% |
384,899
+98,870
| +35% | +$939K |
|
1286
Cimpress
CMPR
$2.39B
| $3.15M | 0.01% |
36,601
+1,133
| +3% | +$98K |
|
|
SFR
1287
DELISTED
Starwood Waypoint Homes
SFR
| $3.15M | 0.01% |
92,907
+7,230
| +8% | +$230K |
|
|
SFBS
1288
ServisFirst Bancshares
SFBS
$4.89B
| $3.15M | 0.01% |
86,650
+24,150
| +39% | +$948K |
|
1289
Empire State Realty Trust
ESRT
$872M
| $3.15M | 0.01% |
152,550
+11,499
| +8% | +$238K |
|
1290
Progress Software
PRGS
$1.66B
| $3.14M | 0.01% |
108,110
+25,919
| +32% | +$753K |
|
1291
E.W. Scripps
SSP
$257M
| $3.13M | 0.01% |
133,620
+28,993
| +28% | +$611K |
|
|
CHSP
1292
DELISTED
Chesapeake Lodging Trust
CHSP
| $3.13M | 0.01% |
130,730
+37,608
| +40% | +$934K |
|
1293
Werner Enterprises
WERN
$2.24B
| $3.13M | 0.01% |
119,494
+1,002
| +0.8% | +$27.3K |
|
|
GRUB
1294
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $3.13M | 0.01% |
47,587
+2,024
| +4% | +$149K |
|
|
WBT
1295
DELISTED
Welbilt, Inc.
WBT
| $3.13M | 0.01% |
159,391
+8,881
| +6% | +$170K |
|
1296
Enpro
NPO
$6.63B
| $3.13M | 0.01% |
43,963
+10,600
| +32% | +$703K |
|
1297
S&T Bancorp
STBA
$1.88B
| $3.13M | 0.01% |
90,305
+19,091
| +27% | +$696K |
|
1298
HUB Group
HUBG
$2.85B
| $3.11M | 0.01% |
134,196
+32,046
| +31% | +$757K |
|
1299
Ultragenyx Pharmaceutical
RARE
$2.45B
| $3.11M | 0.01% |
45,906
+4,278
| +10% | +$326K |
|
|
CBI
1300
DELISTED
Chicago Bridge & Iron Nv
CBI
| $3.08M | 0.01% |
100,293
+6,948
| +7% | +$224K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.